Genotype | Controls (%) (593) | Lung adenocarcinoma | Squamous cell carcinoma | ||||
---|---|---|---|---|---|---|---|
Cases (%) (233) | ORa (95 %CI) | P value | Cases (%) (89) | ORa (95% CI) | P value | ||
Rs4848320 | |||||||
 CC (ref) | 402 (67.8) | 159 (68.2) | 1.00 (ref) |  | 58 (65.2) | 1.00 (ref) |  |
 CT | 175 (29.5) | 68 (29.2) | 0.957 (0.679–1.350) | 0.804 | 28 (31.5) | 1.127 (0.690–1.840) | 0.634 |
 TT | 16 (2.7) | 6 (2.6) | 0.910 (0.343–2.413) | 0.849 | 3 (3.4) | 1.230 (0.339–4.466) | 0.753 |
 CT + TT vs CC |  |  | 0.953 (0.683–1.331) | 0.779 |  | 1.135 (0.706–1.826) | 0.600 |
 TT vs CT + CC |  |  | 0.922 (0.350–2.431) | 0.870 |  | 1.184 (0.329–4.259) | 0.796 |
Rs1110839 | |||||||
 TT (ref) | 250 (42.2) | 102 (43.8) | 1.00 (ref) |  | 30 (33.7) | 1.00 (ref) |  |
 TG | 274 (46.2) | 107 (45.9) | 0.960 (0.691–1.334) | 0.808 | 46 (51.7) | 1.336 (0.813–2.195) | 0.253 |
 GG | 69 (11.6) | 24 (10.3) | 0.805 (0.474–1.368) | 0.423 | 13 (14.6) | 1.605 (0.787–3.273) | 0.193 |
 TG + GG vs TT |  |  | 0.928 (0.678–1.270) | 0.639 |  | 1.388 (0.864–2.229) | 0.175 |
 GG vs TG + TT |  |  | 0.822 (0.498–1.359) | 0.445 |  | 1.362 (0.712–2.608) | 0.350 |